PMC:7161517 / 11609-11799
Annnotations
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T143","span":{"begin":17,"end":19},"obj":"Chemical"}],"attributes":[{"id":"A143","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"Diversion of Ang II towards ACE2 could competitively inhibit viral binding and also counter regulate the adverse effects caused by AT1R and improve outcomes by Mas R−based favorable effects."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":0,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Diversion of Ang II towards ACE2 could competitively inhibit viral binding and also counter regulate the adverse effects caused by AT1R and improve outcomes by Mas R−based favorable effects."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T406","span":{"begin":13,"end":19},"obj":"PR:000036009"},{"id":"T407","span":{"begin":28,"end":32},"obj":"PR:000003622;G_3;PG_10"},{"id":"T408","span":{"begin":61,"end":66},"obj":"NCBITaxon:10239"},{"id":"T409","span":{"begin":131,"end":135},"obj":"PR:000001251"},{"id":"T410","span":{"begin":160,"end":165},"obj":"PR:000001607"},{"id":"T4704","span":{"begin":109,"end":119},"obj":"CHEBI:31547;CHEBI:31547"},{"id":"T67581","span":{"begin":127,"end":132},"obj":"SP_6;NCBITaxon:9606"},{"id":"T67016","span":{"begin":133,"end":141},"obj":"CL:0000576"},{"id":"T80087","span":{"begin":150,"end":161},"obj":"CL:0000235"}],"text":"Diversion of Ang II towards ACE2 could competitively inhibit viral binding and also counter regulate the adverse effects caused by AT1R and improve outcomes by Mas R−based favorable effects."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"496","span":{"begin":28,"end":32},"obj":"Gene"},{"id":"497","span":{"begin":131,"end":135},"obj":"Gene"},{"id":"499","span":{"begin":13,"end":16},"obj":"Gene"}],"attributes":[{"id":"A496","pred":"tao:has_database_id","subj":"496","obj":"Gene:59272"},{"id":"A497","pred":"tao:has_database_id","subj":"497","obj":"Gene:185"},{"id":"A499","pred":"tao:has_database_id","subj":"499","obj":"Gene:283"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Diversion of Ang II towards ACE2 could competitively inhibit viral binding and also counter regulate the adverse effects caused by AT1R and improve outcomes by Mas R−based favorable effects."}